These results suggest that SHMT1 inhibits the AKT/FOXO3 A signaling pathway by promoting ATIC to promote the proliferation, invasion, and EMT of BC cells and reduce their apoptosis level, thereby promoting the malignant progression of bladder cancer. The gene discussed is SHMT1; the disease is urinary bladder carcinoma.